| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2022 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 894 | $36.14 | $32,309.61 | -1.4% | +28.1% | +52.0% | |
| Apr 22, 2022 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 458 | $36.14 | $16,552.76 | -0.6% | +28.1% | +52.0% | |
| Apr 22, 2022 | NTRA Natera, Inc. | Schueren Robert Alan66 | Chief Operating Officer | Sell | 577 | $36.14 | $20,852.84 | -12.8% | +28.1% | +52.0% | |
| Apr 20, 2022 | XWEL Xwell, Inc. | Weinstein Robert61 | Director | Sell | 45,000 | $1.06 | $47,700.00 | -29.7% | -22.9% | -69.5% | |
| Apr 20, 2022 | PMDI Psychemedics Corp | Kamin Peter | 10% Owner | Buy | 43,143 | $6.59 | $284,423.96 | +4.4% | - | - | |
| Apr 20, 2022 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Business Officer | Sell | 6,269 | $2.49 | $15,609.81 | -8.9% | -36.5% | -88.0% | |
| Apr 18, 2022 | XWEL Xwell, Inc. | Milford Scott R62 | Chief Executive Officer | Sell | 25,020 | $1.09 | $27,311.70 | -18.2% | -25.7% | -71.0% | |
| Apr 14, 2022 | TWST Twist Bioscience Corp | Thorburn James M84 | Chief Financial Officer | Sell | 6,620 | $42.85 | $283,682.86 | -6.5% | -0.4% | -67.2% | |
| Apr 14, 2022 | IMDX Insight Molecular Diagnostics Inc. | Pura Vida Investments, LLC | 10% Owner | Buy | 5,931,707 | $1.33 | $7,887,849.58 | +13.5% | -27.8% | -74.7% | |
| Apr 14, 2022 | IMDX Insight Molecular Diagnostics Inc. | Broadwood Partners, L.P.60 | 10% Owner | Buy | 6,003,752 | $1.33 | $7,999,999.54 | +14.7% | -27.8% | -74.7% | |
| Apr 13, 2022 | PSNL Personalis, Inc. | West John Stephen91 | President And CEO | Sell | 64,430 | $0.00 | - | -15.9% | -46.9% | -56.6% | |
| Apr 11, 2022 | CDNA Caredx, Inc. | Goldberg Michael85 | Director | Sell | 500 | $36.01 | $18,006.40 | -0.8% | -32.1% | -75.9% | |
| Apr 8, 2022 | TTOO T2 Biosystems, Inc. | Giffin Brett A. | Chief Commercial Officer | Buy | 10,600 | $0.49 | $5,183.40 | New | - | - | |
| Apr 8, 2022 | TTOO T2 Biosystems, Inc. | Sprague John M | Chief Financial Officer | Buy | 10,000 | $0.48 | $4,767.00 | +7.0% | - | - | |
| Apr 8, 2022 | TTOO T2 Biosystems, Inc. | Barclay Alec | Chief Operations Officer | Buy | 12,952 | $0.50 | $6,475.94 | +7.7% | - | - | |
| Apr 8, 2022 | NTRA Natera, Inc. | Schueren Robert Alan66 | Chief Operating Officer | Sell | 1,999 | $41.91 | $83,779.09 | -37.4% | -5.9% | +20.1% | |
| Apr 8, 2022 | PMDI Psychemedics Corp | Kamin Peter | 10% Owner | Buy | 7,000 | $6.74 | $47,200.00 | +1.8% | - | - | |
| Apr 7, 2022 | BDSX Biodesix Inc | Patience John | - | Buy | 279,329 | $1.79 | $499,998.91 | +476.7% | -12.3% | -3.9% | |
| Apr 7, 2022 | BDSX Biodesix Inc | Strobeck Matthew | - | Buy | 1,117,318 | $1.79 | $1,999,999.22 | +93.3% | -12.3% | -3.9% | |
| Apr 7, 2022 | TTOO T2 Biosystems, Inc. | Sperzel John J III | Chairman, CEO, And President | Buy | 30,000 | $0.50 | $15,000.00 | +15.6% | - | - | |
| Apr 7, 2022 | BDSX Biodesix Inc | Schuler Jack W45 | - | Buy | 2,793,296 | $1.79 | $4,999,999.84 | +33.0% | -12.3% | -3.9% | |
| Apr 7, 2022 | TTOO T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Buy | 10,000 | $0.49 | $4,900.00 | +6.4% | - | - | |
| Apr 6, 2022 | WGS Genedx Holdings Corp. | Ro Isaac89 | Chief Financial Officer | Sell | 1,284 | $2.91 | $3,736.57 | -0.8% | -49.3% | -88.5% | |
| Apr 5, 2022 | CDNA Caredx, Inc. | Maag Peter84 | Director | Sell | 10,000 | $38.64 | $386,394.32 | -1.6% | -33.6% | -77.2% | |
| Apr 4, 2022 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 1,559 | $43.09 | $67,177.31 | -2.4% | -12.9% | +20.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.